Free Trial
NASDAQ:MDXG

MiMedx Group (MDXG) Stock Price, News & Analysis

MiMedx Group logo
$6.28 +0.06 (+0.88%)
Closing price 07/3/2025 03:00 PM Eastern
Extended Trading
$6.16 -0.12 (-1.91%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MiMedx Group Stock (NASDAQ:MDXG)

Key Stats

Today's Range
$6.19
$6.36
50-Day Range
$5.81
$7.43
52-Week Range
$5.47
$10.14
Volume
319,320 shs
Average Volume
674,419 shs
Market Capitalization
$928.29 million
P/E Ratio
23.28
Dividend Yield
N/A
Price Target
$12.50
Consensus Rating
Buy

Company Overview

MiMedx Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

MDXG MarketRank™: 

MiMedx Group scored higher than 69% of companies evaluated by MarketBeat, and ranked 943rd out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MiMedx Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MiMedx Group has received no research coverage in the past 90 days.

  • Read more about MiMedx Group's stock forecast and price target.
  • Earnings Growth

    Earnings for MiMedx Group are expected to grow by 6.67% in the coming year, from $0.30 to $0.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MiMedx Group is 23.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.57.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MiMedx Group is 23.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.40.

  • Price to Book Value per Share Ratio

    MiMedx Group has a P/B Ratio of 4.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MiMedx Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.44% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in MiMedx Group has recently decreased by 3.66%, indicating that investor sentiment is improving.
  • Dividend Yield

    MiMedx Group does not currently pay a dividend.

  • Dividend Growth

    MiMedx Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.44% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 7.7.
  • Change versus previous month

    Short interest in MiMedx Group has recently decreased by 3.66%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MiMedx Group this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for MDXG on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added MiMedx Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MiMedx Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,268,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.70% of the stock of MiMedx Group is held by insiders.

  • Percentage Held by Institutions

    79.15% of the stock of MiMedx Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MiMedx Group's insider trading history.
Receive MDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter.

MDXG Stock News Headlines

MDXG MiMedx Group, Inc. - Seeking Alpha
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Director Of MiMedx Group Makes $185K Buy
MIMEDX to Participate in Upcoming Investor Conferences
Zooming In On MiMedx Group's Earnings
See More Headlines

MDXG Stock Analysis - Frequently Asked Questions

MiMedx Group's stock was trading at $9.62 at the beginning of the year. Since then, MDXG stock has decreased by 34.7% and is now trading at $6.2850.

MiMedx Group, Inc (NASDAQ:MDXG) issued its quarterly earnings data on Wednesday, April, 30th. The company reported $0.06 earnings per share for the quarter, hitting analysts' consensus estimates of $0.06. The business had revenue of $88.21 million for the quarter, compared to the consensus estimate of $86.32 million. MiMedx Group had a trailing twelve-month return on equity of 22.70% and a net margin of 11.40%.
Read the conference call transcript
.

Shares of MDXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MiMedx Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Hawkins (HWKN), Adobe (ADBE) and GE Aerospace (GE).

Company Calendar

Last Earnings
4/30/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MDXG
Employees
870
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.50
High Stock Price Target
$13.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+98.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
23.28
Forward P/E Ratio
20.95
P/E Growth
N/A
Net Income
$42.42 million
Pretax Margin
15.47%

Debt

Sales & Book Value

Annual Sales
$352.38 million
Cash Flow
$0.33 per share
Price / Cash Flow
18.77
Book Value
$1.31 per share
Price / Book
4.80

Miscellaneous

Free Float
145,191,000
Market Cap
$928.31 million
Optionable
Optionable
Beta
1.76
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MDXG) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners